AI Prime
Shanghai
About AI Prime
AI Prime is a life sciences company that develops oncology therapeutics targeting the growth and proliferation of cancer cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2022)
- Website: ai-prime.ai
- Phone: +86 21 6841 3396
Industries & Categories
Artificial Intelligence (AI), Oncology
Social Profiles
Canonical: https://fsome.com/organization/ai-prime-140488 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.